方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| EORTC QLQ-C30：癌症生活质量评估的核心问卷× | COPD评估测试× | |
|---|---|---|
| 领域 | 健康结局 | 健康结局 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1993 | 2009 |
| 提出者≠ | Nico Aaronson et al. | Paul W. Jones et al. |
| 类型≠ | Self-report quality of life questionnaire | Self-report symptom and impact questionnaire |
| 开创性文献≠ | Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376. DOI ↗ | Jones, P. W., Harding, G., Berry, P., Wiklund, I., Chen, W. H., & Kline Leidy, N. (2009). Development and first validation of the COPD Assessment Test. European Respiratory Journal, 34(3), 648-654. DOI ↗ |
| 别名 | QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale | CAT, COPD Assessment Test, COPD Assessment Tool |
| 相关≠ | 5 | 4 |
| 摘要≠ | The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care. | The COPD Assessment Test (CAT) is a simple, rapid, patient-centered measure of COPD symptom burden and functional impact. Developed by Paul Jones and colleagues in 2009, this 8-item questionnaire captures how COPD affects cough, sputum, chest tightness, breathing difficulty, activity limitation, confidence, sleep, and energy. It is used worldwide in clinical practice to guide disease management decisions and as a primary outcome measure in COPD clinical trials. |
| ScholarGate数据集 ↗ |
|
|